RMD
ResMed Inc
NYSE: RMD · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$213.81
+0.89% today
Updated 2026-04-30
Market cap
$30.87B
P/E ratio
20.96
P/S ratio
5.72x
EPS (TTM)
$10.11
Dividend yield
1.04%
52W range
$212 – $292
Volume
1.0M
ResMed Inc (RMD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
27.50%
Operating margin
35.20%
ROE
25.70%
ROA
14.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $607.00M | $88.21M | 62.09% | 21.63% | 14.53% |
| 2007 | $716.33M | $66.30M | 53.68% | 12.59% | 9.26% |
| 2008 | $835.40M | $110.30M | 59.10% | 17.11% | 13.20% |
| 2009 | $920.74M | $146.45M | 60.15% | 20.67% | 15.91% |
| 2010 | $1.09B | $190.09M | 60.01% | 22.01% | 17.40% |
| 2011 | $1.24B | $226.99M | 59.63% | 21.47% | 18.26% |
| 2012 | $1.37B | $254.85M | 59.97% | 21.51% | 18.62% |
| 2013 | $1.51B | $307.13M | 62.11% | 23.43% | 20.28% |
| 2014 | $1.55B | $345.27M | 63.65% | 26.05% | 22.20% |
| 2015 | $1.68B | $352.89M | 60.24% | 24.38% | 21.02% |
| 2016 | $1.84B | $352.41M | 58.00% | 23.33% | 19.17% |
| 2017 | $2.07B | $342.28M | 58.15% | 20.60% | 16.56% |
| 2018 | $2.34B | $315.59M | 58.21% | 23.15% | 13.49% |
| 2019 | $2.61B | $404.59M | 58.95% | 22.22% | 15.52% |
| 2020 | $2.96B | $621.67M | 58.09% | 27.38% | 21.02% |
| 2021 | $3.20B | $474.50M | 57.53% | 28.27% | 14.84% |
| 2022 | $3.58B | $779.44M | 56.57% | 27.96% | 21.78% |
| 2023 | $4.22B | $897.56M | 55.78% | 26.80% | 21.25% |
| 2024 | $4.69B | $1.02B | 56.67% | 28.17% | 21.79% |
| 2025 | $5.15B | $1.40B | 59.36% | 32.75% | 27.22% |